Pregnant women, health workers and people with underlying health problems should receive swine flu vaccines ahead of the rest of the population, EU experts recommended Tuesday.
There was no call for children to be prioritised.
Swine Flu Vaccine Produced by a Chinese Pharmaceutical Company
A Chinese pharmaceutical company announced that it has produced a vaccine for the swine flu virus that is designed to begin working after one dose.
Advertisement
A previous idea to include young people in the list of those to be vaccinated first "was abandoned", an EU source said, without giving a reason.
"All persons from six months old with underlying chronic conditions (e.g. chronic respiratory diseases; chronic cardiovascular diseases and persons with congenital or acquired immunodeficiency)," should be vaccinated first, the experts from the 27 EU nations said in a written statement.
![US Experts To Hold Emergency Meeting On Swine Flu Vaccine]( "US Experts To Hold Emergency Meeting On Swine Flu Vaccine")
US immunization experts have called an emergency meeting to map out a plan for vaccinating Americans against swine flu when influenza season returns in the coming months, a health
Those with the most severe symptoms should be at the head of the queue, they added.
Pregnant women and "health care workers" were the other two categories prioritised by the European Union Health Security Committee and the Early Warning and Response authorities.
The experts, who thus backed proposals from the European Commission, stressed that "it is the responsibility and mandate of each (EU) member state to develop a vaccination strategy for influenza A(H1N1)", known as swine flu.
"The priority groups identified... are indicative and countries may wish to adapt the prioritisation in line with their epidemiology, health services provisions and resources," the experts agreed.
The approach may also need to be changed "as the pandemic progresses".
EU health experts had already declared that there is no point in pre-emptive school closures or delaying the start of the new term in order to tackle swine flu.
Source: AFP
LIN
US Experts To Hold Emergency Meeting On Swine Flu Vaccine
US immunization experts have called an emergency meeting to map out a plan for vaccinating Americans against swine flu when influenza season returns in the coming months, a health
Advertisement
Those with the most severe symptoms should be at the head of the queue, they added.
Pregnant women and "health care workers" were the other two categories prioritised by the European Union Health Security Committee and the Early Warning and Response authorities.
The experts, who thus backed proposals from the European Commission, stressed that "it is the responsibility and mandate of each (EU) member state to develop a vaccination strategy for influenza A(H1N1)", known as swine flu.
"The priority groups identified... are indicative and countries may wish to adapt the prioritisation in line with their epidemiology, health services provisions and resources," the experts agreed.
The approach may also need to be changed "as the pandemic progresses".
EU health experts had already declared that there is no point in pre-emptive school closures or delaying the start of the new term in order to tackle swine flu.
Source: AFP
LIN
New Swine Flu Vaccine May Trigger Deadly Brain Disorder
The British Government has written to senior neurologists to warn them that the new swine flu vaccine may trigger a deadly brain disorder called Guillain-Barre syndrome.
Advertisement
 Flu Vaccination for Health-care Workers RecommendedInfluenza vaccination of health-care workers results in decreased health-care expenditures and improved patient safety and employee safety. | Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
The impact of anti-obesity drugs on survival rates among osteoarthritis patients is under scrutiny, evaluating their potential influence on mortality risks.
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.